Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The MOOD Study - External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for the Treatment of Major Depressive Disorder (MDD)

NCT04279522 is registered in ClinicalTrials.gov with Neurolief Ltd. as lead sponsor.

NCT NCT04279522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04279522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The MOOD Study - External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for the Treatment of Major Depressive Disorder (MDD)
Lead sponsor
Neurolief Ltd.
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2021
Completion date
June 7, 2024
Enrollment
124 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

mdd